撤回声明：MiR-636在绝经后骨质疏松症中的临床价值及其在骨质疏松症进展中的作用 - Suppr

Retraction: Clinical Value of MiR-636 in Postmenopausal Osteoporosis and Its Role in the Progression of Osteoporosis.

作者信息

Ru Zhengliang, Tian Zhong, Yang Yutong, Chen Lusha, Wang Liandi, Peng Xue, Cao Yu, Qin Huiling

机构信息

Department of Orthopedics, The Third People's Hospital Health Care Group of Cixi.

Department of Orthopedics, Chonggang General Hospital.

出版信息

Tohoku J Exp Med. 2024 Nov 7. doi: 10.1620/tjem.2024.J118.

DOI:10.1620/tjem.2024.J118

PMID:39505538

Abstract

摘要

相似文献

Retraction: Clinical Value of MiR-636 in Postmenopausal Osteoporosis and Its Role in the Progression of Osteoporosis.

Tohoku J Exp Med. 2024 Nov 7. doi: 10.1620/tjem.2024.J118.

miR-370-3p affects the progression of postmenopausal osteoporosis through targeting INO80.

Hereditas. 2025 Jul 22;162(1):138. doi: 10.1186/s41065-025-00502-8.

MiR-23a-5p affects postmenopausal osteoporosis by targeting ALX3 to regulate osteoblast differentiation.

J Orthop Surg Res. 2025 Jul 25;20(1):700. doi: 10.1186/s13018-025-06133-z.

LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p.

Hereditas. 2025 Jul 10;162(1):124. doi: 10.1186/s41065-025-00494-5.

Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.

Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526-w.

The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis.

Clin Ther. 2024 Mar;46(3):267-274. doi: 10.1016/j.clinthera.2023.12.010. Epub 2024 Feb 1.

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.

Serum asprosin and its association with bone mineral density, oxidative stress, and osteoprotegerin levels in Pakistani women with postmenopausal osteoporosis.

Expert Rev Endocrinol Metab. 2025 Sep;20(5):427-439. doi: 10.1080/17446651.2025.2510595. Epub 2025 May 31.

Association between lncRNA H19 and osteoporosis in postmenopausal patients with type 2 diabetes mellitus.

J Orthop Surg Res. 2025 Aug 7;20(1):737. doi: 10.1186/s13018-025-06153-9.

Prevalence of postmenopausal osteoporosis in Morocco: a systematic review and meta-analysis.

Arch Osteoporos. 2024 Jul 18;19(1):61. doi: 10.1007/s11657-024-01421-3.

引用本文的文献

MiR-23a-5p affects postmenopausal osteoporosis by targeting ALX3 to regulate osteoblast differentiation.

J Orthop Surg Res. 2025 Jul 25;20(1):700. doi: 10.1186/s13018-025-06133-z.

Overexpression of miR-671-3p alleviates postmenopausal osteoporosis by targeting GREM2 to activate BMP2/SMAD signaling pathway.

Hereditas. 2025 Jun 11;162(1):102. doi: 10.1186/s41065-025-00467-8.

Dysregulation of miR-106a-5p/PTEN axis associated with progression and diagnostic of postmenopausal osteoporosis.

J Orthop Surg Res. 2025 May 13;20(1):456. doi: 10.1186/s13018-025-05872-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Retraction: Clinical Value of MiR-636 in Postmenopausal Osteoporosis and Its Role in the Progression of Osteoporosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Retraction: Clinical Value of MiR-636 in Postmenopausal Osteoporosis and Its Role in the Progression of Osteoporosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献